Hashem B. El‐Serag

1.1k total papers · 96.5k total citations
650 papers, 69.0k citations indexed

About

Hashem B. El‐Serag is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Hashem B. El‐Serag has authored 650 papers receiving a total of 69.0k indexed citations (citations by other indexed papers that have themselves been cited), including 288 papers in Epidemiology, 277 papers in Surgery and 233 papers in Hepatology. Recurrent topics in Hashem B. El‐Serag's work include Liver Disease Diagnosis and Treatment (241 papers), Hepatitis C virus research (144 papers) and Esophageal Cancer Research and Treatment (113 papers). Hashem B. El‐Serag is often cited by papers focused on Liver Disease Diagnosis and Treatment (241 papers), Hepatitis C virus research (144 papers) and Esophageal Cancer Research and Treatment (113 papers). Hashem B. El‐Serag collaborates with scholars based in United States, Italy and United Kingdom. Hashem B. El‐Serag's co-authors include K. Lenhard Rudolph, Jessica A. Davila, Andrew C. Mason, Katherine A. McGlynn, Aaron P. Thrift, Jennifer R. Kramer, Fasiha Kanwal, Yasser H. Shaib, Peter Richardson and Donna L. White and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Hashem B. El‐Serag

626 papers receiving 67.5k citations

Hit Papers

Hepatocellular Carcinoma:... 1999 2026 2008 2017 2007 2011 2012 1999 2020 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
    2007 4.5k citations Hashem B. El‐Serag, K. Lenhard Rudolph Gastroenterology profile →
  2. Hepatocellular Carcinoma
    2011 2.9k citations Hashem B. El‐Serag New England Journal of Medicine profile →
  3. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
    2012 2.5k citations Hashem B. El‐Serag Gastroenterology profile →
  4. Rising Incidence of Hepatocellular Carcinoma in the United States
    1999 2.4k citations Hashem B. El‐Serag, Andrew C. Mason New England Journal of Medicine profile →
  5. Epidemiology of Hepatocellular Carcinoma
    2020 1.3k citations Katherine A. McGlynn, Hashem B. El‐Serag et al. Hepatology profile →
  6. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
    2013 1.3k citations Hashem B. El‐Serag et al. Gut profile →
  7. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
    2020 1.2k citations Daniel Q. Huang, Hashem B. El‐Serag et al. Nature Reviews Gastroenterology & Hepatology profile →
  8. Epidemiology and Management of Hepatocellular Carcinoma
    2018 1.2k citations Laura Kulik, Hashem B. El‐Serag Gastroenterology profile →
  9. Burden of Gastric Cancer
    2019 1000 citations Aaron P. Thrift, Hashem B. El‐Serag Clinical Gastroenterology and Hepatology profile →
  10. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
    2004 962 citations Hashem B. El‐Serag, Thomas Tran et al. Gastroenterology profile →
  11. Esophageal Carcinoma
    2014 953 citations Hashem B. El‐Serag et al. New England Journal of Medicine profile →
  12. Diagnosis and Treatment of Hepatocellular Carcinoma
    2008 913 citations Hashem B. El‐Serag, Jorge A. Marrero et al. Gastroenterology profile →
  13. The Epidemiology of Cholangiocarcinoma
    2004 871 citations Yasser H. Shaib, Hashem B. El‐Serag Seminars in Liver Disease profile →
  14. Epidemiology of Hepatocellular Carcinoma
    2013 861 citations Sahil Mittal, Hashem B. El‐Serag Journal of Clinical Gastroenterology profile →
  15. Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications
    2005 850 citations Howard Hampel, Neena S. Abraham et al. profile →
  16. Hepatocellular carcinoma: Recent trends in the United States
    2004 778 citations Hashem B. El‐Serag Gastroenterology profile →
  17. The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
    2003 759 citations Hashem B. El‐Serag, Jessica A. Davila et al. profile →
  18. Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature
    2011 726 citations Jason K. Hou, Bincy Abraham et al. The American Journal of Gastroenterology profile →
  19. Risk factors for cholangiocarcinoma
    2011 677 citations Gia L. Tyson, Hashem B. El‐Serag Hepatology profile →
  20. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
    2009 673 citations Gary L. Davis, Miriam J. Alter et al. Gastroenterology profile →
  21. The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic Evidence
    2006 623 citations Hashem B. El‐Serag, Howard Hampel et al. Clinical Gastroenterology and Hepatology profile →
  22. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
    2017 618 citations Fasiha Kanwal, Jennifer R. Kramer et al. Gastroenterology profile →
  23. Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
    2012 592 citations Donna L. White, Fasiha Kanwal et al. Clinical Gastroenterology and Hepatology profile →
  24. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
    2003 557 citations Yasser H. Shaib, Jessica A. Davila et al. Journal of Hepatology profile →
  25. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
    2018 550 citations Fasiha Kanwal, Jennifer R. Kramer et al. Gastroenterology profile →
  26. Hepatocellular Carcinoma
    2002 545 citations Hashem B. El‐Serag Journal of Clinical Gastroenterology profile →
  27. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
    2005 535 citations Jessica A. Davila, Robert O. Morgan et al. Gut profile →
  28. The Epidemiology of Malignant Gastrointestinal Stromal Tumors: An Analysis of 1,458 Cases from 1992 to 2000
    2005 483 citations Thomas Tran, Jessica A. Davila et al. The American Journal of Gastroenterology profile →
  29. Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
    2014 481 citations Hashem B. El‐Serag, Fasiha Kanwal Hepatology profile →
  30. Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
    2015 472 citations Sahil Mittal, Hashem B. El‐Serag et al. Clinical Gastroenterology and Hepatology profile →
  31. Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    2017 448 citations Nader N. Massarweh, Hashem B. El‐Serag profile →
  32. The changing pattern of epidemiology in hepatocellular carcinoma
    2010 426 citations Helena Nordenstedt, Donna L. White et al. Digestive and Liver Disease profile →
  33. The Epidemiology of Obesity
    2010 421 citations Dang Nguyen, Hashem B. El‐Serag Gastroenterology Clinics of North America profile →
  34. Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database
    2011 410 citations Tania M. Welzel, Barry I. Graubard et al. Hepatology profile →
  35. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
    2015 407 citations Amit G. Singal, Hashem B. El‐Serag Clinical Gastroenterology and Hepatology profile →
  36. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
    2019 402 citations Paola Bertuccio, Matteo Malvezzi et al. Journal of Hepatology profile →
  37. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
    2023 360 citations Aaron P. Thrift, Theresa Nguyen Wenker et al. Nature Reviews Clinical Oncology profile →
  38. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
    2021 342 citations Fasiha Kanwal, Jay H. Shubrook et al. Gastroenterology profile →
  39. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
    2022 322 citations Daniel Q. Huang, Amit G. Singal et al. Cell Metabolism profile →
  40. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012
    2016 321 citations Donna L. White, Aaron P. Thrift et al. Gastroenterology profile →
  41. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review
    2020 231 citations Rohit Loomba, Joseph K. Lim et al. Gastroenterology profile →
  42. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
    2020 224 citations Maya Balakrishnan, Parth Patel et al. Clinical Gastroenterology and Hepatology profile →
  43. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
    2023 196 citations Josep M. Llovet, Catherine E. Willoughby et al. Nature Reviews Gastroenterology & Hepatology profile →
  44. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
    2022 150 citations Mohammed Eslam, Hashem B. El‐Serag et al. Nature Reviews Gastroenterology & Hepatology profile →
  45. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States
    2022 127 citations Nabihah Tayob, Fasiha Kanwal et al. Clinical Gastroenterology and Hepatology profile →
  46. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
    2024 55 citations James A. Thomas, Bradley J. Kendall et al. ˜The œLancet. Gastroenterology & hepatology profile →
  47. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    2024 50 citations Fasiha Kanwal, Jennifer R. Kramer et al. JAMA Internal Medicine profile →
  48. RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
    2024 41 citations Massimo Rugge, Robert M. Genta et al. Gut profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hashem B. El‐Serag 28.0k 26.1k 23.2k 12.2k 10.6k 650 69.0k
Kazuaki Chayama 15.7k 0.6× 14.9k 0.6× 10.6k 0.5× 7.5k 0.6× 9.8k 0.9× 1.4k 45.2k
Peter R. Galle 16.0k 0.6× 19.2k 0.7× 11.0k 0.5× 11.4k 0.9× 7.4k 0.7× 1.2k 55.3k
Michael P. Manns 41.8k 1.5× 46.7k 1.8× 11.2k 0.5× 10.8k 0.9× 3.3k 0.3× 1.3k 76.6k
Gregory J. Gores 20.1k 0.7× 18.9k 0.7× 23.4k 1.0× 19.3k 1.6× 11.2k 1.1× 587 62.9k
Murray F. Brennan 8.3k 0.3× 6.1k 0.2× 31.6k 1.4× 5.6k 0.5× 43.2k 4.1× 954 80.9k
Francis K.L. Chan 9.3k 0.3× 3.7k 0.1× 15.7k 0.7× 11.5k 0.9× 6.2k 0.6× 629 43.2k
Yuman Fong 9.7k 0.3× 20.0k 0.8× 25.0k 1.1× 5.8k 0.5× 15.9k 1.5× 858 56.4k
Vincent Wai‐Sun Wong 32.7k 1.2× 20.7k 0.8× 7.7k 0.3× 5.0k 0.4× 2.0k 0.2× 633 44.2k
John L. Cameron 10.7k 0.4× 3.8k 0.1× 35.2k 1.5× 7.4k 0.6× 21.4k 2.0× 531 62.2k
Andrew K. Burroughs 24.0k 0.9× 29.5k 1.1× 13.2k 0.6× 2.2k 0.2× 2.6k 0.2× 506 38.7k

Countries citing papers authored by Hashem B. El‐Serag

Since Specialization
Citations

This map shows the geographic impact of Hashem B. El‐Serag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hashem B. El‐Serag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hashem B. El‐Serag more than expected).

Fields of papers citing papers by Hashem B. El‐Serag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hashem B. El‐Serag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hashem B. El‐Serag. The network helps show where Hashem B. El‐Serag may publish in the future.

Co-authorship network of co-authors of Hashem B. El‐Serag

This figure shows the co-authorship network connecting the top 25 collaborators of Hashem B. El‐Serag. A scholar is included among the top collaborators of Hashem B. El‐Serag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hashem B. El‐Serag. Hashem B. El‐Serag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David W. Denning Breakdown of academic impact, for papers by Dong Su Breakdown of academic impact, for papers by Wenbin Lin Breakdown of academic impact, for papers by Alex Pentland Breakdown of academic impact, for papers by Richard E. Mayer Breakdown of academic impact, for papers by Henrica C. W. de Vet Breakdown of academic impact, for papers by Tim Cole Breakdown of academic impact, for papers by Peter A. Ward
Rankless by CCL
2026